Gene: CEACAM19
Official Full Name: CEA cell adhesion molecule 19provided by HGNC
Gene Summary: Predicted to be involved in heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules. Predicted to be located in membrane. Predicted to be active in cell surface. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18845 | CEACAM19 Knockout cell line (HeLa) | Human | CEACAM19 | 1:3~1:6 | Negative | Online Inquiry |
KO18846 | CEACAM19 Knockout cell line (HCT 116) | Human | CEACAM19 | 1:2~1:4 | Negative | Online Inquiry |
KO18847 | CEACAM19 Knockout cell line (HEK293) | Human | CEACAM19 | 1:3~1:6 | Negative | Online Inquiry |
KO18848 | CEACAM19 Knockout cell line (A549) | Human | CEACAM19 | 1:3~1:4 | Negative | Online Inquiry |
CEACAM19 Gene Knockout Cell Lines are specialized cell lines in which the CEACAM19 gene has been inactivated or "knocked out" through advanced genetic engineering techniques. CEACAM19, a member of the carcinoembryonic antigen (CEA) family, is involved in cellular adhesion and signaling pathways that play critical roles in both normal physiological processes and various pathologies, including certain cancers. The knockout of this gene provides researchers with invaluable tools to investigate the gene's specific functions and its contributions to disease mechanisms.
These cell lines function by allowing scientists to observe the effects of the absence of CEACAM19 in a controlled environment, shedding light on its role in cellular processes such as growth, differentiation, and apoptosis. Researchers can utilize these knockout models to explore potential therapeutic targets, especially in the context of tumor biology, where CEACAM19 has been implicated in cancer progression and metastasis.
In terms of scientific importance, CEACAM19 Gene Knockout Cell Lines serve as critical resources for translational research and drug development. They facilitate the elucidation of disease pathways and the validation of new therapies, making them highly relevant in preclinical studies.
Unique selling points of these knockout cell lines include their specificity and reliability, which are crucial for obtaining reproducible and effective experimental outcomes. By utilizing precise gene editing technologies such as CRISPR-Cas9, these cell lines ensure that researchers engage with the most accurate models available, increasing the credibility and impact of their findings.
For researchers, clinicians, and pharmaceutical developers alike, the ability to manipulate specific gene functions opens up a multitude of avenues for innovation in treatment strategies and the understanding of complex diseases.
Our company prides itself on providing high-quality, expertly validated biological products that empower scientists to advance their research. With a commitment to continuous improvement and excellence, we strive to support the scientific community in their quest for knowledge and medical breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.